1
Gracchi, Valentina, van den Belt, Sophie M, Corpeleijn, Eva, Heerspink, Hiddo J L, Verkade, Henkjan J
Veröffentlicht in: Gracchi , V , van den Belt , S M , Corpeleijn , E , Heerspink , H J L & Verkade , H J 2023 , ' Albuminuria and markers for cardiovascular risk in 12-year-olds from the general Dutch population : a cross-sectional study ' , European Journal of Pediatrics , vol. 182 , no. 11 , pp. 4921-4929 . https://doi.org/10.1007/s00431-023-05152-4;
2023
Veröffentlicht in: Gracchi , V , van den Belt , S M , Corpeleijn , E , Heerspink , H J L & Verkade , H J 2023 , ' Albuminuria and markers for cardiovascular risk in 12-year-olds from the general Dutch population : a cross-sectional study ' , European Journal of Pediatrics , vol. 182 , no. 11 , pp. 4921-4929 . https://doi.org/10.1007/s00431-023-05152-4;
2023
2
3
van Mil, Dominique, Kieneker, Lyanne M., Evers-Roeten, Birgitte, Thelen, Marc H.M., de Vries, Hanne, Hemmelder, Marc H., Dorgelo, Annemiek, van Etten, Ronald W., Heerspink, Hiddo J.L., Gansevoort, Ron T.
Veröffentlicht in: van Mil , D , Kieneker , L M , Evers-Roeten , B , Thelen , M H M , de Vries , H , Hemmelder , M H , Dorgelo , A , van Etten , R W , Heerspink , H J L & Gansevoort , R T 2023 , ' Participation rate and yield of two home-based screening methods to detect increased albuminuria in the general population in the Netherlands (THOMAS) : a prospective, randomised, open-label implementation study ' , The Lancet , vol. 402 , no. 10407 , pp. 1052-1064 . https://doi.org/10.1016/S0140-6736(23)00876-0;
2023
Veröffentlicht in: van Mil , D , Kieneker , L M , Evers-Roeten , B , Thelen , M H M , de Vries , H , Hemmelder , M H , Dorgelo , A , van Etten , R W , Heerspink , H J L & Gansevoort , R T 2023 , ' Participation rate and yield of two home-based screening methods to detect increased albuminuria in the general population in the Netherlands (THOMAS) : a prospective, randomised, open-label implementation study ' , The Lancet , vol. 402 , no. 10407 , pp. 1052-1064 . https://doi.org/10.1016/S0140-6736(23)00876-0;
2023
4
Cherney, David Z I, Dekkers, Claire C J, Barbour, Sean J, Cattran, Daniel, Abdul Gafor, Abdul Halim, Greasley, Peter J, Laverman, Gozewijn D, Lim, Soo Kun, Di Tanna, Gian Luca, Reich, Heather N, Vervloet, Marc G, Wong, Muh Geot, Gansevoort, Ron T, Heerspink, Hiddo J L
Veröffentlicht in: DIAMOND investigators , Cherney , D Z I , Dekkers , C C J , Barbour , S J , Cattran , D , Abdul Gafor , A H , Greasley , P J , Laverman , G D , Lim , S K , Di Tanna , G L , Reich , H N , Vervloet , M G , Wong , M G , Gansevoort , R T & Heerspink , H J L 2020 , ' Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non -diabetic patients with chronic kidney disease (DIAMOND) : a randomised, double-blind, crossover trial ' , Lancet Diabetes & Endocrinology , vol. 8 , no. 7 , pp. 582-593 . https://doi.org/10.1016/S2213-8587(20)30162-5;
2020
Veröffentlicht in: DIAMOND investigators , Cherney , D Z I , Dekkers , C C J , Barbour , S J , Cattran , D , Abdul Gafor , A H , Greasley , P J , Laverman , G D , Lim , S K , Di Tanna , G L , Reich , H N , Vervloet , M G , Wong , M G , Gansevoort , R T & Heerspink , H J L 2020 , ' Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non -diabetic patients with chronic kidney disease (DIAMOND) : a randomised, double-blind, crossover trial ' , Lancet Diabetes & Endocrinology , vol. 8 , no. 7 , pp. 582-593 . https://doi.org/10.1016/S2213-8587(20)30162-5;
2020